| 000 | 01635 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513105149.0 | ||
| 264 | 0 | _c19970117 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0007-1048 | ||
| 024 | 7 |
_a10.1046/j.1365-2141.1996.d01-1932.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoreau, P | |
| 245 | 0 | 0 |
_aA pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity. _h[electronic resource] |
| 260 |
_bBritish journal of haematology _cDec 1996 |
||
| 300 |
_a527-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelphalan _xadverse effects |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 700 | 1 | _aKergueris, M F | |
| 700 | 1 | _aMilpied, N | |
| 700 | 1 | _aLe Tortorec, S | |
| 700 | 1 | _aMahé, B | |
| 700 | 1 | _aBulabois, C E | |
| 700 | 1 | _aRapp, M J | |
| 700 | 1 | _aLarousse, C | |
| 700 | 1 | _aBataille, R | |
| 700 | 1 | _aHarousseau, J L | |
| 773 | 0 |
_tBritish journal of haematology _gvol. 95 _gno. 3 _gp. 527-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.1996.d01-1932.x _zAvailable from publisher's website |
| 999 |
_c8936206 _d8936206 |
||